Inhibition of receptor activator of nuclear factor kappa-B ligand pathway for the management of aggressive osteosarcoma.
Department of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Ioannis
I
Panagiotidis
Department of Hematology, 251 General Air-Force Hospital, Athens, Greece.
Dimitrios
D
Christoulas
Department of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Evangelos
E
Terpos